Usefulness of Endoscopic Transpapillary Tissue Sampling for Malignant Biliary Strictures and Predictive Factors of Diagnostic Accuracy

Hiroki Tanaka; Shimpei Matsusaki; Youichirou Baba; Yoshiaki Isono; Tomohiro Sase; Hiroshi Okano; Tomonori Saito; Katsumi Mukai; Tetsuya Murata; Hiroki Taoka

doi:10.5946/ce.2017.082

Articles

Page Path: HOME > Clin Endosc > Volume 51(2); 2018 > Article

Original Article Usefulness of Endoscopic Transpapillary Tissue Sampling for Malignant Biliary Strictures and Predictive Factors of Diagnostic Accuracy: Hiroki Tanaka^1,, Shimpei Matsusaki¹, Youichirou Baba², Yoshiaki Isono¹, Tomohiro Sase¹, Hiroshi Okano¹, Tomonori Saito¹, Katsumi Mukai¹, Tetsuya Murata², Hiroki Taoka³; Clinical Endoscopy 2018;51(2):174-180.
DOI: https://doi.org/10.5946/ce.2017.082
Published online: August 31, 2017

¹Department of Gastroenterology, Suzuka General Hospital, Suzuka, Japan

²Department of Pathology, Suzuka General Hospital, Suzuka, Japan

³Department of Surgery, Suzuka General Hospital, Suzuka, Japan

Correspondence: Hiroki Tanaka Department of Gastroenterology, Suzuka General Hospital, 1275-53 Yamanohana, Yasuzuka, Suzuka 513-0818, Japan Tel: +81-59-382-1311, Fax: +81-59-384-1033, E-mail: hiroki.tanaka@miekosei.or.jp

• Received: May 22, 2017 • Revised: July 14, 2017 • Accepted: July 14, 2017

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

7,198 Views
133 Download
12 Web of Science
11 Crossref
11 Scopus

prev next

Full Article

Download PDF

Abstract
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
NOTES
REFERENCES

See letter "Diagnosis of Malignant Biliary Stricture: More is Better" in Volume 51 on page 115.

Abstract

Background/Aims
It is sometimes difficult to distinguish between malignant and benign biliary strictures using imaging studies alone, and pathological diagnosis is necessary. The aim of this study was to determine the usefulness of endoscopic transpapillary tissue sampling and factors predictive of diagnostic accuracy.
Methods
From April 2008 to December 2014, 136 patients underwent endoscopic transpapillary tissue sampling for malignant biliary strictures. The cytological and histological findings were reported as negative, suspicious, or positive. Suspicious and positive findings were defined as pathologically positive.
Results
The sensitivity was 65.0% for forceps biopsy, 49.5% for brush cytology, 46.2% for bile aspiration cytology, and 21.9% for endoscopic nasobiliary drainage cytology. The combination of these procedures improved the sensitivity (72.8%). Endoscopic transpapillary tissue sampling was more sensitive for lesions of biliary origin (91.4%) than for extrabiliary lesions (66.3%). In surgical cases, the sensitivity for tumors with an infiltrative growth pattern (53.3%) was significantly lower than for a tumor with an expanding or intermediate growth pattern (87.5%).
Conclusions
Combining procedures can improve diagnostic accuracy. It may be possible to predict the sensitivity of endoscopic transpapillary tissue sampling by evaluating the etiology and tumor growth pattern using preoperative imaging studies.
Keywords: Biliary tract neoplasms; Pancreatic neoplasms; Endoscopic retrograde cholangiography; Obstructive janudice

INTRODUCTION

It is sometimes difficult to distinguish between malignant and benign causes of biliary strictures such as immunoglobulin G4-associated sclerosing cholangitis, primary sclerosing cholangitis, and others. Therefore, obtaining a correct pathological diagnosis is important. Most malignant biliary strictures are associated with obstructive jaundice, and endoscopic transpapillary tissue samples obtained by techniques such as forceps biopsy, brush cytology, and aspiration cytology are commonly performed during endoscopic biliary drainage (EBD). Several studies have revealed that combinations of these procedures improved the diagnostic accuracy for malignant biliary strictures [1-9]. However, these procedures have limited sensitivity, and false-negative results are a matter of concern. The etiology of malignant biliary strictures [3-7,10,11], the location of the strictures [6,7,10], the pathological interpretation [4-6,10,12], and other factors reportedly contribute to the diagnosis. However, these factors are not fully understood. In this retrospective study, we evaluated the accuracy of diagnostic procedures and factors contributing to accuracy.

MATERIALS AND METHODS

From April 2008 to December 2014, 136 patients with malignant biliary strictures underwent endoscopic transpapillary tissue sampling. A malignant biliary stricture was defined as the presence of obstructive jaundice due to a malignant tumor. Patients with biliary strictures caused by protruding-type ampullary cancer were excluded from the study. The protocol for endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic transpapillary tissue sampling is described below. ERCP was performed using a side-viewing scope (JF260, TJF 260; Olympus, Tokyo, Japan). After deep cannulation and passage through a stricture, the bile juice above the stricture was aspirated with a catheter (MTW ERCP catheter; MTW Endoskopie, Wesel, Germany). This initially sampled bile juice was not used for aspiration cytology to avoid confusing tumor cells with inflammatory atypia. Cholangiography and endoscopic sphincterotomy were performed before tissue sampling. Endoscopic transpapillary tissue sampling was performed with a biopsy forceps (FB-46Q-1; Olympus), cytology brush (Brush Master V; Olympus, and RX Cytology Brush; Boston Scientific Japan, Tokyo, Japan). Forceps biopsy and brush cytology were performed in all patients except when the devices could not be passed through the stricture. Forceps biopsy preceded other procedures. Bile aspiration cytology was performed after forceps biopsy and/or brush cytology. After endoscopic transpapillary tissue sampling, endoscopic biliary stenting (EBS) or endoscopic nasobiliary drainage (ENBD) was performed at the operator’s discretion. EBS was performed using a 7.0- or 8.5-Fr plastic stent (RX Biliary Stent; Boston Scientific Japan, and Quick Place V Biliary Stent; Olympus), and ENBD was performed using a 5- or 6-Fr tube (Quick Place V ENBD; Olympus). When ENBD was performed for EBD, bile juice obtained from the ENBD tube (but not from the placed bag) was evaluated for cytology (hereinafter referred to as ENBD cytology). ENBD cytology was performed once or twice per day (total of 1–3 times) and discontinued once the diagnosis was obtained. The cytological and histological findings were reported as negative, suspicious (for malignancy), or positive (for malignancy). Suspicious and positive findings were defined as pathologically positive. Pathologically negative cases were classified as insufficient material, inadequate material, normal bile duct epithelium, or inflammatory atypia/reactive change. Cases with negative results on initial endoscopic transpapillary tissue sampling either underwent re-examination with tissue sampling or other procedures such as endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) at the operator’s discretion. Some elderly patients having poor physical status underwent treatment without confirmation of the pathological diagnosis (with most of them receiving the best supportive care). The final diagnosis was made based on the pathological examination of resected specimens, imaging studies, and the patient’s clinical course (≥1 year). Statistical analysis was performed using Pearson’s chi-squared test with Yate’s continuity correction and Fisher’s exact test, and a p-value of <0.05 was considered statistically significant.

RESULTS

Baseline characteristics

Table 1 shows the characteristics of the 136 patients enrolled in this study. The patients consisted of 79 men and 57 women (median age 74 years, range 45–94 years). Of these, 55 had pancreatic cancer, 35 had extrahepatic cholangiocarcinoma (including perihilar cholangiocarcinoma), 25 had gallbladder cancer, 13 had intrahepatic cholangiocarcinoma, 5 had postoperative recurrences, and 3 had other cancers. Of the 136 patients with malignant biliary strictures, forceps biopsy, brush cytology, aspiration cytology, and ENBD cytology were performed in 123 (90.4%), 111 (81.6%), 78 (57.4%), and 32 (23.5%) patients, respectively.

Outcomes of endoscopic transpapillary tissue sampling

The sensitivity was 65.0% (80/123) for forceps biopsy, 49.5% (55/111) for brush cytology, 46.2% (36/78) for bile aspiration cytology, and 21.9% (7/32) for ENBD cytology (Table 2). The sensitivity of the combination of these procedures was 72.8% (99/136), which was significantly higher than that of each procedure alone. The sensitivity of forceps biopsy (65.0%, 80/123) was the highest among all single procedures. Forceps biopsy was negative or not performed in 56 cases, and 50 of these patients underwent other procedures. The sensitivity in these cases was 20.0% (9/45) for brush cytology, 34.3% (12/35) for bile aspiration cytology, and 11.1% (1/9) for ENBD cytology; 19 (38.0%) patients were diagnosed by procedures without forceps biopsy. Among 37 patients in whom the initial endoscopic transpapillary tissue sampling was negative, 12 underwent re-examination with endoscopic transpapillary tissue sampling, and 9 had positive results. In total, 108 (79.4%) patients were diagnosable with endoscopic transpapillary tissue sampling. Among 28 patients in whom endoscopic transpapillary tissue sampling was negative, 5 were diagnosed by EUS-FNA, 4 by liver biopsy, 3 by duodenal biopsy, and 16 by imaging studies (Table 3).

Sensitivity by final diagnosis

The sensitivity using a combination of procedures was 69.1% (38/55) for pancreatic cancer, 91.4% (32/35) for extrahepatic cholangiocarcinoma, 56.0% (14/25) for gallbladder cancer, and 61.5% (8/13) for intrahepatic cholangiocarcinoma (Table 4). Furthermore, malignant biliary strictures were classified as lesions of biliary origin (extrahepatic cholangiocarcinoma) or extrabiliary origin (pancreatic cancer, intrahepatic cholangiocarcinoma, gallbladder cancer, metastatic cancer, and postoperative recurrence). The sensitivity of endoscopic transpapillary tissue sampling for lesions of biliary origin (91.4%, 32/35) was significantly higher than that for extrabiliary lesions (66.3%, 67/101) (Table 5). For each procedure, the sensitivity of forceps biopsy for lesions of biliary origin (84.4%, 27/32) was significantly higher than that for extrabiliary lesions (58.2%, 53/91), however, the sensitivity of brush cytology, aspiration cytology, and ENBD cytology was not significantly different between the biliary and extrabiliary lesions.

Causes of false-negative results

The causes of false-negative results on endoscopic transpapillary tissue sampling were classified as inadequate material, insufficient material, normal bile duct epithelium, or inflammatory atypia/reactive change (some duplication occurred). The most frequent cause of false-negative results on endoscopic transpapillary tissue sampling was the inability to obtain specimens from tumor tissues, regardless of the type of procedure used (Table 6).

Surgical cases

Forty (29.4%) of the 136 enrolled patients underwent surgery. Twenty patients had biliary lesions and 20 had extrabiliary lesions (11 had pancreatic cancer, 7 had gallbladder cancer, 1 had intrahepatic cholangiocarcinoma, and 1 had ampullary cancer). We analyzed the diagnostic sensitivity in these surgical cases according to the cancer infiltrative pattern and stromal volume, based on the Japanese Classification of Biliary Tract Carcinoma and Pancreatic Carcinoma. Two pathologists evaluated cancer infiltrative patterns and stromal volume based on the pathological findings of resected specimens. The cancer infiltrative pattern was classified as INF a (α) (expanding growth pattern), INF b (β) (intermediate growth pattern), or INF c (γ) (infiltrative growth pattern). The diagnostic sensitivity among all patients with INF a (α) or INF b (β) was 87.5% (21/24); among patients with biliary lesions, the sensitivity was 100.0% (14/14), and among those with extrabiliary lesions, the sensitivity was 70.0% (7/10) (Table 7). Conversely, the diagnostic sensitivity among all patients with INF c (γ) was 53.3% (8/15), that among patients with biliary lesions was 66.7% (4/6), and that among patients with extrabiliary lesions was 44.4% (4/9). The sensitivity for inf c (γ) (53.3%) tumors was significantly lower than that for INF a (α) and INF b (β) (87.5%) tumors. The cancer stromal pattern was classified as med (scanty stroma), sci (abundant stroma), or int (intermediate type). The diagnostic sensitivity among all patients with med or int (n=23) was 82.6% (19/23), that among patients with biliary lesions was 92.9% (13/14), and that among patients with extrabiliary lesions was 66.7% (6/9) (Table 8). Conversely, the diagnostic sensitivity among all patients with sci (n=16) was 56.3% (9/16), that among patients with biliary lesions was 66.7% (4/6), and that among patients with extrabiliary lesions was 50.0% (5/10). The sensitivity for tumor with sci (56.3%) was considerably lower than that for a tumor with med or int (82.6%), although the difference was not statistically significant (p=0.15).

Complications

Five (3.7%) patients developed mild pancreatitis that improved with conservative treatment.

DISCUSSION

Malignant biliary strictures are caused by various diseases, including, pancreatic cancer, cholangiocarcinoma, gallbladder cancer, ampullary cancer, metastatic cancer, and others. It is sometimes difficult to distinguish between malignant and benign disease using imaging studies alone. In fact, 6.6% to 9.0% of patients who underwent surgery for suspected malignant biliary strictures were ultimately diagnosed with benign diseases based on the histological findings of the resected specimens [13,14]. Therefore, preoperative pathological examination is important. Most malignant biliary strictures are associated with jaundice, and endoscopic transpapillary tissue sampling is commonly performed during EBD. The reported sensitivity of forceps biopsy, brush cytology, and aspiration cytology were 36.0% to 81.0% [3-9,11,15], 26.0% to 71.6% [3-9,11,12,15], and 30.0% to 72.4% [3,11,15,16], respectively, all of which have room for improvement. Several studies have revealed that a combination of these diagnostic methods improved the sensitivity. In the present study, the sensitivity of forceps biopsy (65.0%) was highest among all single procedures, while a combination of procedures further improved the sensitivity (72.8%). Sugiyama et al. reported that bile and brush cytology were not useful when forceps biopsy was negative [11], and Kurzawinski et al. reported that bile cytology was not useful when brush cytology was negative [17]. However, in the present study, 8 (5.9%) cases were positive on aspiration or ENBD cytology alone. Hence, a combination of methods, including, bile cytology was postulated to be more useful. Abdelghani et al. reported that the sensitivity of ENBD cytology was higher than that of percutaneous transhepatic biliary drainage cytology, and that bile cytology could be improved by scraping the stricture during ENBD [18]. Furthermore, Rabinovitz et al. reported that the sensitivity of brush cytology could be improved by repeating brushing [19]. These reports suggest that scraping the stricture may improve the sensitivity of bile cytology. In the present study, aspiration cytology was performed after forceps biopsy and/or brush cytology; this was partly the reason the combination with bile aspiration was useful.

False-negative results sometimes become a matter of concern during endoscopic transpapillary tissue sampling, and various factors that can influence the diagnostic accuracy include the histopathological interpretation [4-6,10,12], tumor characteristics [3-7,10,12], and procedural factors [4-7,10,12]. Histopathological interpretations vary from one article to another, especially in cases with suspicious results, and close attention is needed when comparing the diagnostic accuracy among these reports. Furthermore, it is sometimes difficult to differentiate inflammatory atypia from malignancy. Thus, we should aspirate the bile juice above the stricture before performing aspiration cytology, especially in patients with combined cholangitis. With respect to tumor characteristics, the presence or absence of direct invasion of the bile duct [3-7,10,11], the underlying etiology [3-7,10,11], and the location of the stricture [6,7,10] were associated with the diagnostic accuracy. Extrabiliary lesions sometimes only compress the bile duct or invade submucosally instead of directly invading the bile duct epithelium. In the present study, the sensitivity of endoscopic transpapillary tissue sampling for biliary lesions (91.4%) was significantly higher than for extrabiliary lesions (66.3%), which is consistent with the findings in previous reports. Among single procedures, the sensitivity of forceps biopsy for biliary lesions (84.4%) was significantly higher than for extrabiliary lesions (58.2%); however, the sensitivity of brush cytology, aspiration cytology, and ENBD cytology was not significantly different between the biliary and extrabiliary lesions. This may suggest that it is important to obtain specimens from the entire stricture in extrabiliary lesions. Furthermore, flow cytometry, molecular genetic studies, and rapid on-site evaluation have been utilized in an attempt to improve diagnostic accuracy when only a small amount of specimen was available [1,2,5,7]. However, some of the lesions in surgical patients in the present study showed no invasion to the bile duct epithelium. In our surgical cases, the sensitivity was significantly lower when the tumor showed an infiltrative growth pattern. Furthermore, the sensitivity was relatively lower, albeit not significantly, when the tumor showed a high cancer stromal volume. We think the probable explanation for these results was the presence of only a few malignant cells on the mucosal surface of the bile duct when the tumor showed an infiltrative growth pattern and high cancer stromal volume. Although better methods and devices are needed, we should recognize that certain cases that are difficult to diagnose by endoscopic transpapillary tissue sampling are present in definite proportions. We may be able to predict the sensitivity of endoscopic transpapillary tissue sampling by evaluating the etiology, tumor growth pattern, and cancer stromal volume based on preoperative imaging studies. EUS-FNA is reportedly useful when endoscopic transpapillary tissue sampling produces negative results, and may be superior, especially for extrabiliary lesions [9,20,21]. We recommend performing EUS-FNA based on the preoperative imaging findings. Procedural factors that influence the diagnostic accuracy are mainly affected by the fact that endoscopic transpapillary tissue sampling is performed under fluoroscopy in two dimensions [4,6,7]. In the present study, the most frequent cause of false-negative results was the inability to obtain specimens from the tumor tissues, regardless of the procedure and underlying etiology. Some recent reports have described SpyGlass (Boston Scientific Japan) cholangioscopy-guided biopsy [22-24]. SpyGlass cholangioscopy makes it possible to perform biopsy under direct visualization, and is useful for both diagnosis of the etiology and determination of disease extent.

This study has certain limitations. It was a retrospective study involving a small number of surgical cases. A further study with a larger number of cases is required to clarify the usefulness of endoscopic transpapillary tissue sampling and the factors predictive of diagnostic accuracy.

In summary, the combination of forceps biopsy, brush cytology, aspiration cytology, and ENBD cytology can improve diagnostic accuracy for malignant biliary strictures. However, certain cases that are difficult to diagnose by endoscopic transpapillary tissue sampling are present in definite proportions. We should chose the most appropriate procedures based on the preoperative imaging findings.

Conflicts of Interest: The authors have no financial conflicts of interest.

Table 1.

Patients’ Characteristics

Male: Female	79: 57
Age (yr)	Mean 74 (45–94)
Final diagnosis
Pancreatic cancer	55
Extrahepatic cholangiocarcinoma	35
Gallbladder cancer	25
Intrahepatic cholangiocarcinoma	13
Ampullary carcinoma	1
Postoperative recurrences	5
Pancreatic neuroendocrine carcinoma	1
Metastatic cancer	1

Table 2.

Sensitivity of Endoscopic Transpapillary Tissue Sampling

(a)	Forceps biopsy	80/123
		65.0%
(b)	Brush cytology	55/111
		49.5%
(c)	Aspiration cytology	36/78
		46.2%
(d)	ENBD cytology	7/32
		21.9%
(e)	Combination of each procedure	99/136
		72.8%

P<0.05: (a) vs. (e), (b) vs. (e), (c) vs. (e), (d) vs. (e).

ENBD, endoscopic nasobiliary drainage.

Table 3.

Negative Results on Endoscopic Transpapillary Tissue Sampling

	Methods for diagnosis
Pancreatic cancer (n=14)	EUS-FNA 4, liver biopsy 1, duodenal biopsy 2
Pancreatic cancer (n=14)	Imaging studies 7
Intrahepatic cholangiocarcinoma (n=4)	Liver biopsy 2
Intrahepatic cholangiocarcinoma (n=4)	Imaging studies 2
Gallbladder cancer (n=4)	Imaging studies 4
Extrahepatic cholangiocarcinoma (n=2)	Imaging studies 2
Postoperative recurrences (n=2)	Liver biopsy 1
Postoperative recurrences (n=2)	Imaging studies 1
Pancreatic neuroendocrine carcinoma (n=1)	EUS-FNA 1
Ampullary carcinoma (n=1)	Duodenal biopsy 1

EUS-FNA, endoscopic ultrasound-guided fine needle aspiration.

Table 4.

Sensitivity of Endoscopic Transpapillary Tissue Sampling by Final Diagnosis

	Forceps biopsy	Brush cytology	Aspiration cytology	ENBD cytology	Total
Pancreatic cancer (n=55)	30/51	23/47	11/29	1/9	38/55
Pancreatic cancer (n=55)	58.8%	48.9%	37.9%	11.1%	69.1%
Extrahepatic cholangiocarcinoma (n=35)	27/32	16/27	11/21	2/10	32/35
Extrahepatic cholangiocarcinoma (n=35)	84.4%	59.3%	52.4%	20.0%	91.4%
Gallbladder cancer (n=25)	14/22	11/22	11/19	3/9	14/25
Gallbladder cancer (n=25)	63.6%	50.0%	57.9%	33.3%	56.0%
Intrahepatic cholangiocarcinoma (n=13)	6/11	3/11	2/6	1/3	8/13
Intrahepatic cholangiocarcinoma (n=13)	54.5%	27.3%	33.3%	33.3%	61.5%

ENBD, endoscopic nasobiliary drainage.

Table 5.

Sensitivity of Endoscopic Transpapillary Tissue Sampling by Final Diagnosis (Biliary-Origin Lesions vs. Extrabiliary-Origin Lesions)

	Biliary-origin lesions (n=35)	Extrabiliary-origin lesions (n=101)	p-value
Forceps biopsy	27/32	53/91	0.00923
Forceps biopsy	84.4%	58.2%
Brush cytology	16/27	39/84	0.28
Brush cytology	59.3%	46.4%
Aspiration cytology	11/21	25/57	0.61
Aspiration cytology	52.4%	43.9%
ENBD cytology	2/10	5/22	1.00
ENBD cytology	20.0%	22.7%
Total	32/35	67/101	0.00378
Total	91.4%	66.3%

ENBD, endoscopic nasobiliary drainage.

Table 6.

Causes of False-Negative Results

	Inadequate material	Insufficient material	Normal bile duct epithelium	Inflammatory atypia/Reactive change
Forceps biopsy	4/43	5/43	33/43	3/43
Forceps biopsy	9.3%	11.6%	76.7%	7.0%
Brush cytology	3/56	4/56	54/56	0/56
Brush cytology	5.4%	7.1%	96.4%	0%
Brush cytology	4/42	1/42	38/42	0/42
Brush cytology	9.5%	2.4%	90.5%	0%
Aspiration cytology	1/25	1/25	23/25	2/25
Aspiration cytology	4.0%	4.0%	92.0%	8.0%

Table 7.

Sensitivity by Cancer Infiltrative Pattern

	Inf a (α), b (β)	Inf c (γ)	p-value
Biliary-origin lesions (n=20)	14/14	4/6	0.079
Biliary-origin lesions (n=20)	100%	66.7%
Extrabiliary-origin lesions (n=19)	7/10	4/9	0.369
Extrabiliary-origin lesions (n=19)	70.0%	44.4%
Total (n=39)	21/24	8/15	0.027
Total (n=39)	87.5%	53.3%

Table 8.

Sensitivity by Cancer Stromal Volume

	Med, int	Sci	p-value
Biliary-origin lesions (n=20)	13/14	4/6	0.20
Biliary-origin lesions (n=20)	92.9%	66.7%
Extrabiliary-origin lesions (n=19)	6/9	5/10	0.65
Extrabiliary-origin lesions (n=19)	66.7%	50.0%
Total (n=39)	19/23	9/16	0.15
Total (n=39)	82.6%	56.3%

REFERENCES

1. Navaneethan U, Njei B, Lourdusamy V, Konjeti R, Vargo JJ, Parsi MA. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc 2015;81:168–176.Article PubMed PMC
2. de Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (part 2). Gastrointest Endosc 2002;56:720–730.Article PubMed
3. Lee SJ, Lee YS, Lee MG, Lee SH, Shin E, Hwang JH. Triple-tissue sampling during endoscopic retrograde cholangiopancreatography increases the overall diagnostic sensitivity for cholangiocarcinoma. Gut Liver 2014;8:669–673.Article PubMed PMC PDF
4. Jailwala J, Fogel EL, Sherman S, et al. Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc 2000;51(4 Pt 1):383–390.Article PubMed
5. Ponchon T, Gagnon P, Berger F, et al. Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc 1995;42:565–572.Article PubMed
6. Pugliese V, Conio M, Nicolò G, Saccomanno S, Gatteschi B. Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study. Gastrointest Endosc 1995;42:520–526.Article PubMed
7. Schoefl R, Haefner M, Wrba F, et al. Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. Scand J Gastroenterol 1997;32:363–368.Article PubMed
8. Kitajima Y, Ohara H, Nakazawa T, et al. Usefulness of transpapillary bile duct brushing cytology and forceps biopsy for improved diagnosis in patients with biliary strictures. J Gastroenterol Hepatol 2007;22:1615–1620.Article PubMed
9. Rösch T, Hofrichter K, Frimberger E, et al. ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study. Gastrointest Endosc 2004;60:390–396.Article PubMed
10. De Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (part 1). Gastrointest Endosc 2002;56:552–561.Article PubMed
11. Sugiyama M, Atomi Y, Wada N, Kuroda A, Muto T. Endoscopic transpapillary bile duct biopsy without sphincterotomy for diagnosing biliary strictures: a prospective comparative study with bile and brush cytology. Am J Gastroenterol 1996;91:465–467.PubMed
12. Logrono R, Kurtycz DF, Molina CP, Trivedi VA, Wong JY, Block KP. Analysis of false-negative diagnoses on endoscopic brush cytology of biliary and pancreatic duct strictures: the experience at 2 university hospitals. Arch Pathol Lab Med 2000;124:387–392.PubMed
13. Gerritsen A, Molenaar IQ, Bollen TL, et al. Preoperative characteristics of patients with presumed pancreatic cancer but ultimately benign disease: a multicenter series of 344 pancreatoduodenectomies. Ann Surg Oncol 2014;21:3999–4006.Article PubMed
14. Abraham SC, Wilentz RE, Yeo CJ, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all ‘chronic pancreatitis’? Am J Surg Pathol 2003;27:110–120.Article PubMed
15. Yagioka H, Hirano K, Isayama H, et al. Clinical significance of bile cytology via an endoscopic nasobiliary drainage tube for pathological diagnosis of malignant biliary strictures. J Hepatobiliary Pancreat Sci 2011;18:211–215.Article PubMed
16. Uchida N, Kamada H, Ono M, et al. How many cytological examinations should be performed for the diagnosis of malignant biliary stricture via an endoscopic nasobiliary drainage tube? J Gastroenterol Hepatol 2008;23:1501–1504.Article PubMed
17. Kurzawinski T, Deery A, Dooley J, Dick R, Hobbs K, Davidson B. A prospective controlled study comparing brush and bile exfoliative cytology for diagnosing bile duct strictures. Gut 1992;33:1675–1677.Article PubMed PMC
18. Abdelghani YA, Arisaka Y, Masuda D, et al. Bile aspiration cytology in diagnosis of bile duct carcinoma: factors associated with positive yields. J Hepatobiliary Pancreat Sci 2012;19:370–378.Article PubMed
19. Rabinovitz M, Zajko AB, Hassanein T, et al. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures. Hepatology 1990;12(4 Pt 1):747–752.Article PubMed
20. Weilert F, Bhat YM, Binmoeller KF, et al. EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study. Gastrointest Endosc 2014;80:97–104.Article PubMed
21. Ohshima Y, Yasuda I, Kawakami H, et al. EUS-FNA for suspected malignant biliary strictures after negative endoscopic transpapillary brush cytology and forceps biopsy. J Gastroenterol 2011;46:921–928.Article PubMed
22. Kurihara T, Yasuda I, Isayama H, et al. Diagnostic and therapeutic single-operator cholangiopancreatoscopy in biliopancreatic diseases: prospective multicenter study in Japan. World J Gastroenterol 2016;22:1891–1901.Article PubMed PMC
23. Woo YS, Lee JK, Oh SH, et al. Role of SpyGlass peroral cholangioscopy in the evaluation of indeterminate biliary lesions. Dig Dis Sci 2014;59:2565–2570.Article PubMed
24. Tieu AH, Kumbhari V, Jakhete N, et al. Diagnostic and therapeutic utility of SpyGlass^® peroral cholangioscopy in intraductal biliary disease: single-center, retrospective, cohort study. Dig Endosc 2015;27:479–485.Article PubMed

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

A new tool for bile duct tissue sampling: ex vivo clinical evaluation of intraductal cryobiopsy for cholangioscopy
Lukas Wirsing, Walter Linzenbold, Simon U. Jaeger, Phillip Stahl, German Ott, Tobias Leibold, Markus Enderle, Jörg Albert, Jan Peveling-Oberhag
Endoscopy International Open.2022; 10(06): E809. CrossRef
Increased accuracy of FNA-based cytological diagnosis of pancreatic lesions by use of an ethanol-based fixative system: A STROBE compliant study
Martin Bürger, Antje Heidrich, Iver Petersen, Andreas Stallmach, Carsten Schmidt
Medicine.2022; 101(36): e30449. CrossRef
Comparison of the Diagnostic Performance of Novel Slim Biopsy Forceps with Conventional Biopsy Forceps for Biliary Stricture: A Multicenter Retrospective Study
Eun Suk Jung, Se Woo Park, Jung Hee Kim, Jang Han Jung, Min Jae Yang, Da Hae Park
Journal of Personalized Medicine.2021; 11(1): 55. CrossRef
Factors affecting the diagnostic yield of endoscopic transpapillary forceps biopsy in patients with malignant biliary strictures
Min Jae Yang, Jae Chul Hwang, Dakeun Lee, Young Bae Kim, Byung Moo Yoo, Jin Hong Kim
Journal of Gastroenterology and Hepatology.2021; 36(8): 2324. CrossRef
Tissue sampling for biliary strictures using novel elbow biopsy forceps
Huahui Zhang, Chunyan Huo, Yongxin Guo, Keyuan Zhu, Fengdong Li, Jin Huang
Scientific Reports.2021;[Epub] CrossRef
Tips and tricks for the diagnosis and management of biliary stenosis-state of the art review
Giovanna Del Vecchio Blanco, Michelangela Mossa, Edoardo Troncone, Renato Argirò, Andrea Anderloni, Alessandro Repici, Omero Alessandro Paoluzi, Giovanni Monteleone
World Journal of Gastrointestinal Endoscopy.2021; 13(10): 473. CrossRef
Ethanol-based fixation is superior to conventional brush cytology in the evaluation of indeterminate biliary strictures by endoscopic retrograde cholangiography
Martin Bürger, Antje Besser, Iver Petersen, Andreas Stallmach, Carsten Schmidt
Medicine.2020; 99(5): e18920. CrossRef
Endoscopic retrograde cholangiopancreatography guided interventions in the management of pancreatic cancer
Muhammad Nadeem Yousaf, Hamid Ehsan, Ahsan Wahab, Ahmad Muneeb, Fizah S Chaudhary, Richard Williams, Christopher J Haas
World Journal of Gastrointestinal Endoscopy.2020; 12(10): 323. CrossRef
Percutaneous transhepatic cholangiobiopsy
Thiago Franchi Nunes, Tiago Kojun Tibana, Rômulo Florêncio Tristão Santos, Bernardo Bacelar de Faria, Edson Marchiori
Radiologia Brasileira.2019; 52(1): 41. CrossRef
Factors Associated with Malignant Biliary Strictures in Patients with Atypical or Suspicious Cells on Brush Cytology
Ji Young Park, Tae Joo Jeon
Clinical Endoscopy.2019; 52(2): 168. CrossRef
Diagnosis of Malignant Biliary Stricture: More is Better
Hyun Jik Lee, Kwang Bum Cho
Clinical Endoscopy.2018; 51(2): 115. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Usefulness of Endoscopic Transpapillary Tissue Sampling for Malignant Biliary Strictures and Predictive Factors of Diagnostic Accuracy

Clin Endosc. 2018;51(2):174-180. Published online August 31, 2017

DOI: https://doi.org/10.5946/ce.2017.082

XML Download

Usefulness of Endoscopic Transpapillary Tissue Sampling for Malignant Biliary Strictures and Predictive Factors of Diagnostic Accuracy

Male: Female	79: 57
Age (yr)	Mean 74 (45–94)
Final diagnosis
Pancreatic cancer	55
Extrahepatic cholangiocarcinoma	35
Gallbladder cancer	25
Intrahepatic cholangiocarcinoma	13
Ampullary carcinoma	1
Postoperative recurrences	5
Pancreatic neuroendocrine carcinoma	1
Metastatic cancer	1

(a)	Forceps biopsy	80/123
		65.0%
(b)	Brush cytology	55/111
		49.5%
(c)	Aspiration cytology	36/78
		46.2%
(d)	ENBD cytology	7/32
		21.9%
(e)	Combination of each procedure	99/136
		72.8%

	Methods for diagnosis
Pancreatic cancer (n=14)	EUS-FNA 4, liver biopsy 1, duodenal biopsy 2
Pancreatic cancer (n=14)	Imaging studies 7
Intrahepatic cholangiocarcinoma (n=4)	Liver biopsy 2
Intrahepatic cholangiocarcinoma (n=4)	Imaging studies 2
Gallbladder cancer (n=4)	Imaging studies 4
Extrahepatic cholangiocarcinoma (n=2)	Imaging studies 2
Postoperative recurrences (n=2)	Liver biopsy 1
Postoperative recurrences (n=2)	Imaging studies 1
Pancreatic neuroendocrine carcinoma (n=1)	EUS-FNA 1
Ampullary carcinoma (n=1)	Duodenal biopsy 1

	Forceps biopsy	Brush cytology	Aspiration cytology	ENBD cytology	Total
Pancreatic cancer (n=55)	30/51	23/47	11/29	1/9	38/55
Pancreatic cancer (n=55)	58.8%	48.9%	37.9%	11.1%	69.1%
Extrahepatic cholangiocarcinoma (n=35)	27/32	16/27	11/21	2/10	32/35
Extrahepatic cholangiocarcinoma (n=35)	84.4%	59.3%	52.4%	20.0%	91.4%
Gallbladder cancer (n=25)	14/22	11/22	11/19	3/9	14/25
Gallbladder cancer (n=25)	63.6%	50.0%	57.9%	33.3%	56.0%
Intrahepatic cholangiocarcinoma (n=13)	6/11	3/11	2/6	1/3	8/13
Intrahepatic cholangiocarcinoma (n=13)	54.5%	27.3%	33.3%	33.3%	61.5%

	Biliary-origin lesions (n=35)	Extrabiliary-origin lesions (n=101)	p-value
Forceps biopsy	27/32	53/91	0.00923
Forceps biopsy	84.4%	58.2%
Brush cytology	16/27	39/84	0.28
Brush cytology	59.3%	46.4%
Aspiration cytology	11/21	25/57	0.61
Aspiration cytology	52.4%	43.9%
ENBD cytology	2/10	5/22	1.00
ENBD cytology	20.0%	22.7%
Total	32/35	67/101	0.00378
Total	91.4%	66.3%

	Inadequate material	Insufficient material	Normal bile duct epithelium	Inflammatory atypia/Reactive change
Forceps biopsy	4/43	5/43	33/43	3/43
Forceps biopsy	9.3%	11.6%	76.7%	7.0%
Brush cytology	3/56	4/56	54/56	0/56
Brush cytology	5.4%	7.1%	96.4%	0%
Brush cytology	4/42	1/42	38/42	0/42
Brush cytology	9.5%	2.4%	90.5%	0%
Aspiration cytology	1/25	1/25	23/25	2/25
Aspiration cytology	4.0%	4.0%	92.0%	8.0%

	Inf a (α), b (β)	Inf c (γ)	p-value
Biliary-origin lesions (n=20)	14/14	4/6	0.079
Biliary-origin lesions (n=20)	100%	66.7%
Extrabiliary-origin lesions (n=19)	7/10	4/9	0.369
Extrabiliary-origin lesions (n=19)	70.0%	44.4%
Total (n=39)	21/24	8/15	0.027
Total (n=39)	87.5%	53.3%

	Med, int	Sci	p-value
Biliary-origin lesions (n=20)	13/14	4/6	0.20
Biliary-origin lesions (n=20)	92.9%	66.7%
Extrabiliary-origin lesions (n=19)	6/9	5/10	0.65
Extrabiliary-origin lesions (n=19)	66.7%	50.0%
Total (n=39)	19/23	9/16	0.15
Total (n=39)	82.6%	56.3%

Table 1. Patients’ Characteristics

Table 2. Sensitivity of Endoscopic Transpapillary Tissue Sampling

P<0.05: (a) vs. (e), (b) vs. (e), (c) vs. (e), (d) vs. (e).

ENBD, endoscopic nasobiliary drainage.

Table 3. Negative Results on Endoscopic Transpapillary Tissue Sampling

EUS-FNA, endoscopic ultrasound-guided fine needle aspiration.

Table 4. Sensitivity of Endoscopic Transpapillary Tissue Sampling by Final Diagnosis

ENBD, endoscopic nasobiliary drainage.

Table 5. Sensitivity of Endoscopic Transpapillary Tissue Sampling by Final Diagnosis (Biliary-Origin Lesions vs. Extrabiliary-Origin Lesions)